首页> 外文OA文献 >Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

【2h】

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

机译：是否有必要推迟抗病毒治疗3-6个月，以预测HBV基因型C流行区HBeag阳性慢性乙型肝炎患者的HBeag血清学转换？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Byung-Cheol Song; Yoo-Kyung Cho; Hyeyoung Jwa; Eun Kwang Choi; Heung Up Kim; Hyun Joo Song; Soo-Young Na; Sun-Jin Boo; Seung Uk Jeong;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroconversion during antiviral treatment [J] . Hao Ran, Xiang Kuanhui, Peng Yaqin, Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases . 2015,第Null期

机译：HBeAg阳性慢性乙型肝炎患者HBV全基因组序列中自然发生的缺失/插入突变与基线血清HBsAg和HBeAg水平相关，并可能预测抗病毒治疗期间HBeAg丢失和血清转化的间隔时间较短
2. Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients. [J] . Lu HY, Zhuang LW, Yu YY, World journal of gastroenterology : . 2008,第8期

机译：抗病毒药物和HBV基因型对HBeAg阳性慢性乙型肝炎患者肝内共价闭合环状DNA的影响。
3. THE SECOND-GENERATION HEPATITIS B VIRUS (HBV) CORE INHIBITOR (CI) ABI-H2158 IS ASSOCIATED WITH POTENT ANTIVIRAL ACTIVITY IN A 14-DAY MONOTHERAPY STUDY IN HBeAg-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) [J] . Yuen Man-Fung, Agarwal Kosh, Gane Edward J., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2019,第6期

机译：第二代乙型肝炎病毒（HBV）核心抑制剂（CI）ABI-H2158与慢性乙型肝炎（CHB）的HBeAG阳性患者的14天单疗法研究中有效抗病毒活性有关
4. Analysis of HBV-DNA in Hepatitis B Patients with HBeAg Negative in JiLin Area [C] . Chen Zhao, Yang Zhao, Zhong-hai Yuan, International Forum on Materials Analysis and Testing Technology . 2014

机译：吉林地区HBEAG阴性患者HBV-DNA分析
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C? [O] . Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, 2014

机译：是否有必要将抗病毒治疗推迟3-6个月以预期HBeAg阳性C型流行地区HBeAg阳性慢性乙型肝炎患者的HBeAg血清学转换？
7. Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients [O] . Lu, Hai-Ying, Zhuang, Li-Wei, Yu, Yan-Yan, 2008

机译：抗病毒药物和HBV基因型对HBeAg阳性慢性乙型肝炎患者肝内共价闭合环状DNA的影响

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

著录项

相似文献

相关主题

期刊订阅